Cell Therapeutics, Inc. (CTIC) Misses Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
Financial Fact:
Loss from operations: -28.66M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Loss from operations: -28.66M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Cell Therapeutics, Inc. (NASDAQ: CTIC) reported Q4 EPS of ($0.06), $0.04 worse than the analyst estimate of ($0.02).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- Red River Bancshares, Inc. (RRBI) Tops Q3 EPS by 7c
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
